UK Begins Testing Ridgeback/Merck Oral RNA Antiviral Drug EIDD-2801
 
The UK AGILE program, has begun testing its first potential therapy that could alter the course of the pandemic. 
$MRK  $MOR $BVS $ALXN #treatment #investment #stocks #RNA #COVID https://t.co/rzKEyXlBqj